Risk Factors of Strom et al for Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement in a Patient Being Treated for Oropharyngeal Squamous Cell Carcinoma
Strom et al reported risk factors for percutaneous endoscopic gastrostomy (PEG) tube placement in a patient being treated for oropharyngeal carcinoma. These can help to identify a patient who is more likely to undergo the procedure for nutritional support. The authors are from Moffitt Cancer Center in Tampa.
Patient selection: oropharyngeal squamous cell carcinoma, during chemoradiation
Placement of a PEG tube during chemoradiation occurred in lower risk patients, with high risk patients have the PEG tube placed before therapy.
Parameters:
(1) radiation therapy schedule
(2) body mass index (BMI) in kg per square meters
Radiation Therapy Schedule
Body Mass Index
Percent PEG Placement
accelerated
NA
28%
conventional
< 25 kg per sq m
24%
conventional
>= 25 kg per sq m
6%
Other factors associated with PEG tube placement:
(1) T3 or T4
(2) cumulative cisplatin doe >= 200 mg per square meter
To read more or access our algorithms and calculators, please log in or register.
